BIOMAT Database Logo BIOMAT Database Logo

[Experimental studies of the antituberculous activity of kanamycin in vitro]. 1958

G CURCI, and V GUIDI

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

G CURCI, and V GUIDI
[Experimental antituberculous activity of kanamycin].
January 1962, Pathologie et biologie,
G CURCI, and V GUIDI
The antituberculous activity of kanamycin in vitro and in the experimental animal (guinea pig).
January 1959, American review of tuberculosis,
G CURCI, and V GUIDI
The antituberculous activity of kanamycin in vitro and in the experimental animal (guinea pig).
September 1958, Annals of the New York Academy of Sciences,
G CURCI, and V GUIDI
[The experimental studies on antituberculous activity of lividomycin].
May 1972, Kekkaku : [Tuberculosis],
G CURCI, and V GUIDI
[Studies on antituberculous activity of lividomycin in vitro].
October 1971, Kekkaku : [Tuberculosis],
G CURCI, and V GUIDI
Cycloserine: antituberculous activity in vitro and in the experimental animal.
April 1956, American review of tuberculosis,
G CURCI, and V GUIDI
Antituberculous activity of thiocarbanidin in vitro and in the experimental animal.
October 1958, American review of tuberculosis,
G CURCI, and V GUIDI
[Studies on the antituberculous activity of 4, 4'-diisoamyloxythiocarvanilide in vitro].
September 1968, Bulletin of the Chest Disease Research Institute, Kyoto University,
G CURCI, and V GUIDI
Studies on the kanamycin resistance in Mycobacterium tuberculosis. IV. The combined effect of various antituberculous drugs with kanamycin in delaying the emergence of kanamycin resistance.
November 1959, The Journal of antibiotics,
G CURCI, and V GUIDI
[Antituberculous activity of capreomycin and cross resistance to kanamycin, capreomycin, and viomycin. 2. In vitro study of cross resistance to capreomycin, kanamycin and viomycin].
September 1969, Bulletin of the Chest Disease Research Institute, Kyoto University,
Copied contents to your clipboard!